Publications - Page 34 sur 57 - RespiFIL - Filière de santé des maladies respiratoires rares

Voici les publications scientifiques relatives aux maladies respiratoires rares auxquelles les membres de la filière ont contribué, classées par groupes de pathologies (depuis juillet 2021).

Pneumopathies interstitielles diffuses (PID)
Recent advances in the management of systemic sclerosis-associated interstitial lung disease.

Hoffmann-Vold AM, Distler O, Crestani B, Antoniou KM.

Curr Opin Pulm Med. 2022 Sep 1;28(5):441-447.
Pneumopathies interstitielles diffuses (PID)
Clinical Impact of Surgical Lung Biopsy for Interstitial Lung Disease in a Reference Center.

Le Guen P, Iquille J, Debray MP, Guyard A, Roussel A, Borie R, Dombret MC, Dupin C, Ghanem M, Taille C, Khalil A, Castier Y, Cazes A, Crestani B, Mordant P.

Ann Thorac Surg. 2022 Sep;114(3):1022-1028.
Pneumopathies interstitielles diffuses (PID)
Hemorrhage in a patient with Bronchial Dieulafoy’s disease and associated pulmonary fibrosis: A case report.

Tankeré P, Favrolt N, Yavordios S, Guerin AC, Georges M, Bonniaud P.

Respir Med Case Rep. 2022 Oct 25;40:101756.
Pneumopathies interstitielles diffuses (PID)
Effect of Nintedanib on Progression of Systemic Sclerosis-Associated Interstitial Lung Disease Over 100 Weeks: Data From a Randomized Controlled Trial.

Assassi S, Distler O, Allanore Y, Ogura T, Varga J, Vettori S, Crestani B, Voss F, Alves M, Stowasser S, Maher TM; SENSCIS trial investigators.

ACR Open Rheumatol. 2022 Oct;4(10):837-844.
Pneumopathies interstitielles diffuses (PID)
Progressive pulmonary fibrosis: all roads lead to Rome (but not all at the same speed).

Cottin V, Valenzuela C.

Eur Respir J. 2022 Oct 6;60(4):2201449.
Pneumopathies interstitielles diffuses (PID)
Diagnosis and monitoring of systemic sclerosis-associated interstitial lung disease using high-resolution computed tomography.

Khanna D, Distler O, Cottin V, Brown KK, Chung L, Goldin JG, Matteson EL, Kazerooni EA, Walsh SL, McNitt-Gray M, Maher TM.

J Scleroderma Relat Disord. 2022 Oct;7(3):168-178.
Pneumopathies interstitielles diffuses (PID)
Drug-induced interstitial lung disease.

Spagnolo P, Bonniaud P, Rossi G, Sverzellati N, Cottin V.

Eur Respir J. 2022 Oct 27;60(4):2102776.
Pneumopathies interstitielles diffuses (PID)
Effect of Nintedanib on Progression of Systemic Sclerosis-Associated Interstitial Lung Disease Over 100 Weeks: Data From a Randomized Controlled Trial.

Assassi S, Distler O, Allanore Y, Ogura T, Varga J, Vettori S, Crestani B, Voss F, Alves M, Stowasser S, Maher TM; SENSCIS trial investigators.

ACR Open Rheumatol. 2022 Oct;4(10):837-844.
Pneumopathies interstitielles diffuses (PID)
A Risk Score to Detect Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease.

Juge PA, Granger B, Debray MP, Ebstein E, Louis-Sidney F, Kedra J, Doyle TJ, Borie R, Constantin A, Combe B, Flipo RM, Mariette X, Vittecoq O, Saraux A, Carvajal-Alegria G, Sibilia J, Berenbaum F, Kannengiesser C, Boileau C, Sparks JA, Crestani B, Fautrel B, Dieudé P.

Arthritis Rheumatol. 2022 Nov;74(11):1755-1765.
Pneumopathies interstitielles diffuses (PID)
Instability of Mature ABCA3 Protein: Toward a New Classification of ABCA3 Mutations?

Onnée M, Duriez B, Simon S, Szczepaniak C, Guguin A, Epaud R, Hamouda S, Fanen P, de Becdelièvre A.

Am J Respir Cell Mol Biol. 2022 Nov;67(5):602-605.

FILTRER :

Par mot clé

Par maladies

Réinitialiser les filtres

Recent advances in the management of systemic sclerosis-associated interstitial lung disease.

Clinical Impact of Surgical Lung Biopsy for Interstitial Lung Disease in a Reference Center.

Hemorrhage in a patient with Bronchial Dieulafoy’s disease and associated pulmonary fibrosis: A case report.

Effect of Nintedanib on Progression of Systemic Sclerosis-Associated Interstitial Lung Disease Over 100 Weeks: Data From a Randomized Controlled Trial.

Progressive pulmonary fibrosis: all roads lead to Rome (but not all at the same speed).

Diagnosis and monitoring of systemic sclerosis-associated interstitial lung disease using high-resolution computed tomography.

Drug-induced interstitial lung disease.

Effect of Nintedanib on Progression of Systemic Sclerosis-Associated Interstitial Lung Disease Over 100 Weeks: Data From a Randomized Controlled Trial.

A Risk Score to Detect Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease.

Instability of Mature ABCA3 Protein: Toward a New Classification of ABCA3 Mutations?